Panagora Asset Management’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-351
Closed -$90K 2147
2021
Q2
$90K Hold
351
﹤0.01% 1928
2021
Q1
$105K Buy
+351
New +$105K ﹤0.01% 1994
2020
Q3
Sell
-712
Closed -$247K 2735
2020
Q2
$247K Buy
712
+460
+183% +$160K ﹤0.01% 1459
2020
Q1
$68K Sell
252
-216
-46% -$58.3K ﹤0.01% 1812
2019
Q4
$151K Sell
468
-299
-39% -$96.5K ﹤0.01% 1696
2019
Q3
$209K Sell
767
-12,466
-94% -$3.4M ﹤0.01% 1615
2019
Q2
$7.06M Sell
13,233
-838
-6% -$447K 0.03% 415
2019
Q1
$7.09M Buy
14,071
+9,327
+197% +$4.7M 0.03% 425
2018
Q4
$2.34M Sell
4,744
-3,438
-42% -$1.7M 0.01% 723
2018
Q3
$7.48M Buy
8,182
+1,115
+16% +$1.02M 0.03% 423
2018
Q2
$5.18M Sell
7,067
-17,022
-71% -$12.5M 0.02% 514
2018
Q1
$38.4M Sell
24,089
-18,327
-43% -$29.2M 0.15% 144
2017
Q4
$38M Sell
42,416
-13,167
-24% -$11.8M 0.14% 160
2017
Q3
$20M Sell
55,583
-1,747
-3% -$629K 0.08% 247
2017
Q2
$16.8M Sell
57,330
-19,893
-26% -$5.83M 0.07% 283
2017
Q1
$27.2M Buy
77,223
+4,882
+7% +$1.72M 0.11% 199
2016
Q4
$13.3M Buy
72,341
+8,289
+13% +$1.53M 0.06% 315
2016
Q3
$16.5M Sell
64,052
-25,079
-28% -$6.46M 0.08% 259
2016
Q2
$19M Buy
89,131
+416
+0.5% +$88.8K 0.09% 220
2016
Q1
$18.3M Sell
88,715
-1,663
-2% -$343K 0.09% 228
2015
Q4
$22.8M Buy
90,378
+3,784
+4% +$956K 0.11% 191
2015
Q3
$14.2M Sell
86,594
-3,688
-4% -$606K 0.08% 269
2015
Q2
$16.9M Buy
90,282
+16,992
+23% +$3.19M 0.08% 253
2015
Q1
$12.1M Buy
73,290
+9,297
+15% +$1.53M 0.06% 301
2014
Q4
$14.9M Buy
63,993
+6,138
+11% +$1.43M 0.08% 253
2014
Q3
$10.5M Buy
57,855
+1,406
+2% +$255K 0.05% 329
2014
Q2
$10.9M Sell
56,449
-3,161
-5% -$608K 0.05% 327
2014
Q1
$10.8M Buy
59,610
+1,635
+3% +$297K 0.05% 338
2013
Q4
$9.87M Buy
57,975
+569
+1% +$96.9K 0.05% 373
2013
Q3
$9M Sell
57,406
-2,958
-5% -$464K 0.04% 365
2013
Q2
$10.5M Buy
+60,364
New +$10.5M 0.05% 294